Balchem Corp Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Balchem Corp has an operating margin of 19.2%, meaning the company retains $19 of operating profit per $100 of revenue. This strong profitability earns a score of 96/100, reflecting efficient cost management and pricing power. This is up from 17.3% the prior year.
Balchem Corp's revenue grew a modest 3.4% year-over-year to $953.7M. This slow but positive growth earns a score of 38/100.
Balchem Corp carries a low D/E ratio of 0.37, meaning only $0.37 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.
Balchem Corp's current ratio of 1.99 indicates adequate short-term liquidity, earning a score of 60/100. The company can meet its near-term obligations, though with limited headroom.
Balchem Corp's ROE of 11.2% shows moderate profitability relative to equity, earning a score of 45/100. This is up from 10.3% the prior year.
Balchem Corp scores 10.25, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($5.9B) relative to total liabilities ($425.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Balchem Corp passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Balchem Corp generates $1.42 in operating cash flow ($182.0M OCF vs $128.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
This page shows Balchem Corp (BCPC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Balchem Corp generated $953.7M in revenue in fiscal year 2024. This represents an increase of 3.4% from the prior year.
Balchem Corp's EBITDA was $230.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.8% from the prior year.
Balchem Corp reported $128.5M in net income in fiscal year 2024. This represents an increase of 18.4% from the prior year.
Balchem Corp earned $3.93 per diluted share (EPS) in fiscal year 2024. This represents an increase of 17.3% from the prior year.
Balchem Corp held $49.5M in cash against $0 in long-term debt as of fiscal year 2024.
Balchem Corp paid $0.87 per share in dividends in fiscal year 2024. This represents an increase of 10.1% from the prior year.
Balchem Corp had 33M shares outstanding in fiscal year 2024. This represents an increase of 0.8% from the prior year.
Balchem Corp's gross margin was 35.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 2.5 percentage points from the prior year.
Balchem Corp's operating margin was 19.2% in fiscal year 2024, reflecting core business profitability. This is up 1.9 percentage points from the prior year.
Balchem Corp's net profit margin was 13.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 1.7 percentage points from the prior year.
Balchem Corp's ROE was 11.2% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the prior year.
Balchem Corp invested $16.8M in research and development in fiscal year 2024. This represents an increase of 11.6% from the prior year.
Balchem Corp spent $5.7M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents an increase of 27.1% from the prior year.
BCPC Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $267.6M+4.7% | $255.5M+2.0% | $250.5M+4.4% | $240.0M0.0% | $239.9M+2.5% | $234.1M-2.3% | $239.7M+4.8% | $228.7M |
| Cost of Revenue | $172.1M+6.0% | $162.4M0.0% | $162.4M+5.7% | $153.7M-0.6% | $154.6M+2.3% | $151.1M-4.5% | $158.1M+2.9% | $153.7M |
| Gross Profit | $95.5M+2.5% | $93.1M+5.6% | $88.2M+2.1% | $86.3M+1.1% | $85.4M+2.9% | $83.0M+1.8% | $81.5M+8.7% | $75.0M |
| R&D Expenses | $4.5M+4.6% | $4.3M-7.8% | $4.7M+3.4% | $4.5M+4.2% | $4.3M+12.3% | $3.9M-6.0% | $4.1M+4.2% | $3.9M |
| SG&A Expenses | $17.3M-4.3% | $18.1M+16.1% | $15.6M-9.8% | $17.3M-1.2% | $17.5M+14.1% | $15.3M-12.5% | $17.5M+30.2% | $13.4M |
| Operating Income | $54.6M+6.1% | $51.4M+0.8% | $51.0M+7.5% | $47.4M-1.1% | $48.0M+4.8% | $45.8M+9.9% | $41.7M+8.7% | $38.3M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | -$5.4M-2.0% | -$5.3M |
| Income Tax | $11.8M+9.5% | $10.7M-1.4% | $10.9M-0.1% | $10.9M+8.4% | $10.1M+9.8% | $9.2M+16.4% | $7.9M+18.8% | $6.6M |
| Net Income | $40.3M+5.3% | $38.3M+3.3% | $37.1M+10.3% | $33.6M-0.8% | $33.8M+5.5% | $32.1M+10.6% | $29.0M+8.8% | $26.6M |
| EPS (Diluted) | $1.24+6.0% | $1.17+3.5% | $1.13+9.7% | $1.030.0% | $1.03+5.1% | $0.98+10.1% | $0.89+8.5% | $0.82 |
BCPC Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B-1.0% | $1.7B+3.8% | $1.6B+2.7% | $1.6B-1.4% | $1.6B+1.4% | $1.6B-0.9% | $1.6B-0.5% | $1.6B |
| Current Assets | $343.7M-5.8% | $364.9M+7.2% | $340.2M+8.4% | $313.8M-3.7% | $326.0M+1.8% | $320.2M-1.4% | $324.9M+3.4% | $314.2M |
| Cash & Equivalents | $65.1M-0.5% | $65.4M+31.1% | $49.9M+0.8% | $49.5M-32.8% | $73.7M+15.6% | $63.7M+5.6% | $60.3M-6.4% | $64.4M |
| Inventory | $132.4M-10.6% | $148.2M+2.2% | $144.9M+10.8% | $130.8M+10.4% | $118.5M+1.2% | $117.1M+6.1% | $110.4M+0.8% | $109.5M |
| Accounts Receivable | $131.5M-3.3% | $136.0M+4.2% | $130.4M+9.0% | $119.7M-0.7% | $120.5M-2.3% | $123.4M-11.8% | $139.9M+11.7% | $125.3M |
| Goodwill | $816.5M0.0% | $816.4M+2.9% | $793.1M+1.7% | $780.0M-0.1% | $781.1M+1.4% | $770.0M-0.2% | $771.5M-0.9% | $778.9M |
| Total Liabilities | $363.2M-11.5% | $410.3M+0.4% | $408.9M-3.9% | $425.5M+1.4% | $419.7M-9.3% | $462.6M-9.3% | $509.9M-6.1% | $543.2M |
| Current Liabilities | $126.4M-8.5% | $138.1M-1.0% | $139.6M-11.5% | $157.7M+44.1% | $109.4M-3.4% | $113.3M-8.9% | $124.4M-16.2% | $148.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.3B+2.4% | $1.3B+4.9% | $1.2B+5.1% | $1.1B-2.3% | $1.2B+5.8% | $1.1B+3.1% | $1.1B+2.4% | $1.1B |
| Retained Earnings | $1.1B+3.8% | $1.1B+3.7% | $1.0B+3.7% | $997.5M+0.5% | $992.4M+3.5% | $958.5M+3.5% | $926.5M+3.2% | $897.5M |
BCPC Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $65.6M+38.8% | $47.3M+29.6% | $36.5M-30.3% | $52.3M+2.0% | $51.3M+14.0% | $45.0M+34.8% | $33.4M-50.5% | $67.4M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$14.9M-125.7% | -$6.6M-12.0% | -$5.9M+84.0% | -$37.0M-302.6% | -$9.2M-33.9% | -$6.9M-1.8% | -$6.7M+43.2% | -$11.9M |
| Financing Cash Flow | -$50.8M-76.7% | -$28.8M+10.0% | -$32.0M+9.2% | -$35.2M-2.4% | -$34.4M-0.6% | -$34.2M-13.9% | -$30.0M+57.2% | -$70.1M |
| Dividends Paid | $11K+450.0% | $2K-100.0% | $28.3M+706475.0% | $4K0.0% | $4K-69.2% | $13K-99.9% | $25.6M | $0 |
| Share Buybacks | $15.4M-53.6% | $33.3M+524.7% | $5.3M+1640.2% | $306K+87.7% | $163K+1381.8% | $11K-99.8% | $5.2M+1071.6% | $444K |
BCPC Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.7%-0.8pp | 36.4%+1.3pp | 35.2%-0.8pp | 36.0%+0.4pp | 35.6%+0.1pp | 35.5%+1.5pp | 34.0%+1.2pp | 32.8% |
| Operating Margin | 20.4%+0.3pp | 20.1%-0.2pp | 20.4%+0.6pp | 19.8%-0.2pp | 20.0%+0.4pp | 19.6%+2.2pp | 17.4%+0.6pp | 16.8% |
| Net Margin | 15.1%+0.1pp | 15.0%+0.2pp | 14.8%+0.8pp | 14.0%-0.1pp | 14.1%+0.4pp | 13.7%+1.6pp | 12.1%+0.4pp | 11.7% |
| Return on Equity | 3.1%+0.1pp | 3.0%-0.1pp | 3.1%+0.2pp | 2.9%+0.1pp | 2.9%0.0pp | 2.9%+0.2pp | 2.7%+0.2pp | 2.5% |
| Return on Assets | 2.4%+0.1pp | 2.3%0.0pp | 2.3%+0.2pp | 2.1%0.0pp | 2.1%+0.1pp | 2.0%+0.2pp | 1.8%+0.2pp | 1.7% |
| Current Ratio | 2.72+0.1 | 2.64+0.2 | 2.44+0.4 | 1.99-1.0 | 2.98+0.2 | 2.83+0.2 | 2.61+0.5 | 2.12 |
| Debt-to-Equity | 0.28-0.0 | 0.32-0.0 | 0.34-0.0 | 0.37+0.0 | 0.36-0.1 | 0.42-0.1 | 0.47-0.0 | 0.52 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Balchem Corp's annual revenue?
Balchem Corp (BCPC) reported $953.7M in total revenue for fiscal year 2024. This represents a 3.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Balchem Corp's revenue growing?
Balchem Corp (BCPC) revenue grew by 3.4% year-over-year, from $922.4M to $953.7M in fiscal year 2024.
Is Balchem Corp profitable?
Yes, Balchem Corp (BCPC) reported a net income of $128.5M in fiscal year 2024, with a net profit margin of 13.5%.
What is Balchem Corp's earnings per share (EPS)?
Balchem Corp (BCPC) reported diluted earnings per share of $3.93 for fiscal year 2024. This represents a 17.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Balchem Corp's EBITDA?
Balchem Corp (BCPC) had EBITDA of $230.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Balchem Corp's gross margin?
Balchem Corp (BCPC) had a gross margin of 35.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Balchem Corp's operating margin?
Balchem Corp (BCPC) had an operating margin of 19.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Balchem Corp's net profit margin?
Balchem Corp (BCPC) had a net profit margin of 13.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Balchem Corp pay dividends?
Yes, Balchem Corp (BCPC) paid $0.87 per share in dividends during fiscal year 2024.
What is Balchem Corp's return on equity (ROE)?
Balchem Corp (BCPC) has a return on equity of 11.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Balchem Corp's operating cash flow?
Balchem Corp (BCPC) generated $182.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Balchem Corp's total assets?
Balchem Corp (BCPC) had $1.6B in total assets as of fiscal year 2024, including both current and long-term assets.
How much does Balchem Corp spend on research and development?
Balchem Corp (BCPC) invested $16.8M in research and development during fiscal year 2024.
Does Balchem Corp buy back shares?
Yes, Balchem Corp (BCPC) spent $5.7M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does Balchem Corp have outstanding?
Balchem Corp (BCPC) had 33M shares outstanding as of fiscal year 2024.
What is Balchem Corp's current ratio?
Balchem Corp (BCPC) had a current ratio of 1.99 as of fiscal year 2024, which is generally considered healthy.
What is Balchem Corp's debt-to-equity ratio?
Balchem Corp (BCPC) had a debt-to-equity ratio of 0.37 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Balchem Corp's return on assets (ROA)?
Balchem Corp (BCPC) had a return on assets of 8.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Balchem Corp's Altman Z-Score?
Balchem Corp (BCPC) has an Altman Z-Score of 10.25, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Balchem Corp's Piotroski F-Score?
Balchem Corp (BCPC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Balchem Corp's earnings high quality?
Balchem Corp (BCPC) has an earnings quality ratio of 1.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Balchem Corp?
Balchem Corp (BCPC) scores 67 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.